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Human neutrophils preloaded with chlortetracycline, commonly used as a probe of membrane-bound 
calcium, demonstrate a prompt decrease in fluorescence when exposed to surface stimuli such as the 
chemotactic peptide fMet-Leu-Phe. The fluorescence r sponse was highly sensitive to preincubation with 
prostaglandin Ex. This effect was apparently not due to elevated levels of CAMP sink exogenous dibutyryl- 
CAMP did not alter the chlo&tracycline fluorescence r sponse to fMet-Leu-Phe. This is one of the few 
instances ofprostaglandin 131 affecting neutrophils at physiologic concentrations, dissociated from changes 
in cellular cyclic nucleotide l vels. 
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1. INTRODUCTION 
Exposure of human neutrophils to any one of a 
variety of stimuli provokes a cascade of 
measurable responses, such as superoxide anion 
generation and lysosomal enzyme release, both of 
which are delayed relative to stimulation [l]. A 
search for the earliest responses to stimulation has 
focussed on the mobilization of intracellular 
calcium. For this purpose, the fluorescent probe 
chlortetracycline (CTC) has been employed in this 
[2-5) and other [6,7] cellular systems. CTC is 
reported to form fluorescent chelates with 
membrane-bound calcium, the mobilization of 
which can be monitored as a decrease in 
fluorescence [6,7]. In human neutrop~s, the CTC 
fluorescence response is rapid, taking place within 
5 s, making it concurrent with or faster than other 
known responses [l-3]. This response is also unaf- 
Abbreviations: CTC, chlo~~racyc~ne; fMet-Leu-Phe, 
IV-formylmethionyl-leucyl-phenylalanine 
fected by agents which inhibit later, apparently 
distal, responses uch as lysosomal enzyme release 
[2,5]. Finally, depletion of the pool of membrane- 
bound calcium mo~tored by CTC, either by prior 
stimulation [3] or exposure to inhibitors of 
glycolytic metabolism [I!], results in hyporespon- 
siveness with respect to both the CTC response and 
enzyme secretion. All of these data suggest that 
CTC is monitoring an early, critical event in 
neu~ophil activation. 
Human neutrophils also respond to surface 
stimulation by a prompt, transient increment in 
CAMP levels [9,10]. However, the significance of 
this increment in stimulus-response coupling has 
been uncertain [9-l 1 J. Platelets also respond to 
stimulation by decreases in CTC fluorescence and 
it has recently been reported that levels of 
membrane-bound calcium are modulated by cyclic 
nucleotides in these bodies [12]. Consequently, it 
was of interest to see if these agents had any effect 
on the CTC fluorescence r sponse of neutrophils. 
In brief, we found that this response was highly 
sensitive to PGEl, but not to cyclic nucleotides. 
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2. MATERIALS AND METHODS 
Chlorotetracycline, dibutyryl-CAMP, dibutyryl- 
cGMP, and PGEr were purchased from Sigma (St 
Louis MO). N-Formyl-methionyl-leucyl- 
phenylalanine @Met-Leu-Phe) was obtained 
from Peninsula Labs (San C&OS CA). 
Cytochalasin B was purchased from the Aldrich 
Chemical Company (Milwaukee WI). 
Purified preparations of human neutrop~ls 
were isolated from heparinized (10 unitslrnl) 
venous blood by means of Hypaque/Ficoll gra- 
dients [13] followed by standard techniques of dex- 
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Fig, 1, Effect of PGEI on the chlortetracycline 
fluorescence response to met-Leu-Phe. Human 
ueutrophils, which were preloaded with CTC, were 
preiacubated with the indicated concentrations of PGEt 
for 5 min at 37°C. At the time shown by the arrow, 
fMet-Leu-Phe ffOv7 M) was added to the sample and 
the fluorescence was continuously recorded. 
tran sedimentation and hypotonic lysis of 
erythrocytes [14]. The cells were washed and final- 
Ly suspended in a buffer consisting of 138 mM 
NaCl, 2.7 mM KCl, 8.1 mM NazHPG4, 1,5 mM 
KHzP04, 1 mM CaC12, and 0.6 mM MgC12, pH 
7.4. Lysosomal enzyme release, enzyme assays, 
and chlortetracycline fluorescence measurements 
were performed as in [2,3]. 
3. RESULTS 
Human neutrophi~ were preloaded with CTC 
and their fluorescence response to fMet-Leu-Phe 
was continuously recorded. As shown in fig. 1, the 
response to chemotactic peptide was inhibited by 
as little as 4 nM PGEr; inhibition increased with 
prostaglandin concentration, reaching a maximum 
at 37-125 nM. The threshold concentration at 
which PGEr first inhibited the CTC fluorescence 
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Fig.2. Effect of dibutyry&AMP on the chtortetracycllne 
fluorescence response to met-Leu-Phe. Human 
neutrophils, which were preloaded with CTC, were 
preincubated with the indicated concentrations of 
&butyryl-cAMP for 5 min at 37°C. At the time shown 
by the arrow, fMet-Leu-Phe j1W’ M) was added to the 
sample and the fluorescence was continuously recorded. 
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response was variable, with inhibition being 
observed at as low as 0.4 nM. High concentrations 
of PGEr produced little or no additional inhibi- 
tion. Under no circumstances, even at PGEi con- 
centrations as high as 250,uM, was the CTC 
fluorescence response abolished by this agent. 
Since one of the primary means by which PGEr 
exerts its effects on cellular function is by 
modulating cyclic nucleotide metabolism, we ex- 
amined the effect of exogenous cyclic nucleotides 
on the CTC fluorescence response. As shown in 
fig.2 and 3, both dibutyryl-CAMP and dibutyryl- 
cGMP were without effect upon this response. In- 
creasing the preincubation period up to 30 min did 
not substantially alter these results (not shown). 
Failure of dibutyryl-CAMP to inhibit stimulated 
changes in CTC fluorescence was not affected by 
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Fig.3. Effect of dibutyryl-cGMP on the chlortetracycline 
fluorescence response to fMet-Leu-Phe. Human 
neutrophils, which were preloaded with CTC, were 
preincubated with the indicated concentrations of 
dibutyryl-cGMP for 5 min at 37°C. At the time shown 
by the arrow, fMet-Leu-Phe (lo-’ M) was added to the 
sample and the fluorescence was continuously recorded. 
Table 1 
Effect of cyclic nucleotides on lysosomal enzyme release 
Enzyme release (@IO control) 
P-Glucuronidase Lysozyme 
No additions (100) (100) 
Dibutyryl-CAMP 
500 /M 77.3 f 1.6 81.7 + 2.3 
150,uM 97.7 f 8.0 87.7 f 13.8 
50 CM 103.0 + 7.9 94.3 + 6.1 
Dibutyryl-cGMP 
50 pM 92.8 f 4.5 87.7 f 6.1 
15,uM 99.1 f 16.5 95.5 + 8.7 
5/IM 97.6 f 18.0 91.1 Zk 1.5 
Human neutrophils were preincubated with cytochalasin 
B (5 pg/ml) and the indicated concentration of cyclic 
nucleotide for 5 min at 37°C. The cells were stimulated 
with fMet-Leu-Phe (lo-’ M) for 5 min and the results 
are expressed as the means ( f SD; n = 3) of percentages 
of enzymes secreted by control neutrophils to which no 
cyclic nucleotides were added. These control cells 
released 39.9 f 5.4% of their &glucuronidase and 
41.7 f 2.0% of total lysozyme 
the presence or absence of cytochalasin B and/or 
theophylline (not shown). That these concentra- 
tions of dibutyryl-CAMP were adequate to inhibit 
cellular function is shown in table 1; secretion of 
both &glucuronidase and lysozyme in response to 
fMet-Leu-Phe were significantly inhibited by 
high concentrations of this agent. 
4. DISCUSSION 
We found that the CTC fluorescence response of 
human neutrophils to fMet-Leu-Phe was 
significantly inhibited, but not abolished, by low 
concentrations of PGEr; in contrast, this response 
was unaffected by high concentrations of 
dibutyryl-CAMP. The concentrations of PGEi 
which produced a significant inhibition of this 
response were 2-3 orders of magnitude lower than 
those customarily necessary to affect neutrophil 
responses [11,15,16]. This dose range was also 
similar to that which effectively inhibited the CTC 
fluorescence response in platelets [12]. Thus, this 
effect is one of the few neutrophil responses which 
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Other workers, using pfat&ts, noted that inhibi- 
tion of the CTC fluorescence r sponse by PGEl 
correlated with elevated CAMP levels induced by 
this agent [12], They concluded that inhibition of 
the fluorescence r sponse was attributable to these 
elevated levels of cyclic nucleotides, Our data in- 
dicate that this mechanism is not operating in 
human neutrophils. The CTC fluorescence 
response to fMet-Leu-Phe was not affected by 
~o~~e~~a~ons of ~butyry~~A~P up to 500 M, a 
~o~~en~~on which has been found to be effective 
by others 415, I 9-221. From knowledge of the tota 
cehular CAMP content 191, it can be calculated that 
the intracellular concentration of this nucleotide is 
about 1 FM. Permeation of only a small fraction 
of the exogenous dibutyryl-CAMP would increase 
the intracellular levels manifold, and exposure to 
this agent should be no less efficacious than 
pretrUment with high (micromolar) concentra- 
tions of PC& fi 1,2@ Thus, i~ib~~~~ of the CTC 
fiuorescenee response did not appear to correlate 
with cycle nuojeotide l vels; rather, ~~b~t~on was 
found at very Iow PGEs ~on~e~~r~tio~ which do 
not affect ceflufar responses and which do not 
substantially alter intracellular cAh&P contents 
uu* 
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Tha fact that PGEr can inhibit the CTC 
fluorescence response without aharing other 
cellular responses, such as lysosomal enzyme 
releaset does not exclude that process monitored 
by the probe as an initial requirement for cell ac- 
tivation, The effect of increasing co~~~ntr~~ons of 
PGEr reached a plateau at 129 r&B, with higher 
~~~~e~tra~o~ p~du~~ no add~tj~~~ b~~on_ 
Since the CTC ~uor~~n~e response was never 
abolished, it is likely that the remaining portion 
was nonetheless sufficient, either in quantity or 
subcr?lllular localization, to triggt?r subsequent 
responsczs. Thus, these results are compatible with 
the hypothesis that the CTC fluorescatrce r sponse 
measures some crucial early step in 
stimulus-response coupling. 
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